A/HRC/17/43 49. On the basis of the presentations and discussions, the Special Rapporteur believes the expert consultation suggests that States should: (a) Establish an adequate legal framework for the realization of the right to access to medicines; (b) Ensure that medicine-related health priorities are not weakened in favour of investment or industrial priorities; (c) Take measures to ensure equality for all individuals and groups, such as disadvantaged minorities; (d) In formulating national health and medicines policies and programmes, ensure the active and informed participation of all concerned – not only of professional organizations and universities, but rural communities, civil society organizations and patients’ and consumer organizations as well; (e) medicines; Establish a regulatory system to ensure the safety and quality of (f) Establish a national medicine supply system that includes programmes specifically tailored to reach vulnerable groups; (g) medicines; Establish monitoring and accountability mechanisms for access to (h) Ensure price and quality control of medicines, and establish dosage standards and ensure the efficacy of medicines; (i) Ensure that procurement practices and procedures are transparent, fair and competitive; (j) Establish mechanisms to limit the impact of intellectual property rights and protect unhindered access to medicines; (k) Ensure that countries are able to take full advantage of TRIPS flexibilities, and to comply with them; (l) Enhance the transfer of technology and investment in research and development to developing countries; (m) Strengthen the effectiveness of national and international measures to ensure access to medicines for all. 14 GE.11-11842